Tag: tse:4503

October 5, 2018

Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program

Cytokinetics (Nasdaq:CYTK) and Astellas Pharma (TSE:4503) today provided an update for their collaborative skeletal muscle program, including clinical trial updates...
August 21, 2018

Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation

Astellas Pharma (TSE:4503) and Ironwood Pharmaceuticals (Nasdaq:IRWD) announced that approval has been obtained in Japan for the guanylate cyclase-C receptor...